Berberine-INF55 (5-Nitro-2-Phenylindole) Hybrid Antimicrobials: Effects of Varying the Relative Orientation of the Berberine and INF55 Components

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.01715-09PMID 20498327PMCID PMC2916310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efflux-Mediated Drug Resistance in Bacteria

  2012cited by this paper
• Synthesis of Berberine—Efflux Pump Inhibitor Hybrid Antibacterials

  2010cited by this paper
• Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group.

  2009cited by this paper
• Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps.

  2008cited by this paper
• Bacterial Resistance to Antimicrobials (2nd ed.)

  2008cited by this paper
• Recent Advances in the Discovery of Hybrid Antibacterial Agents

  2008cited by this paper
• Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

  2008cited by this paper
• Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.

  2007cited by this paper
• Efflux pumps as antimicrobial resistance mechanisms

  2007cited by this paper
• Dual action-based approaches to antibacterial agents.

  2007cited by this paper
• Multidrug Effl ux Pumps: Structure, Mechanism, and Inhibition

  2007cited by this paper
• Some approaches to new antibacterial agents

  2007cited by this paper
• Microbes have the last word

  2007cited by this paper
• Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

  2006cited by this paper
• Unmet medical needs in antibacterial therapy.

  2006cited by this paper
• Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.

  2006cited by this paper
• NorC, a New Efflux Pump Regulated by MgrA of Staphylococcus aureus

  2006cited by this paper
• Conjugating Berberine to a Multidrug Resistance Pump Inhibitor Creates an Effective Antimicrobial

  2006cited by this paper
• Identification of novel antimicrobials using a live-animal infection model

  2006cited by this paper
• Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial.

  2006cited by this paper
• Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus.

  2006cited by this paper
• Multidrug Resistance in Staphylococcus aureus Due to Overexpression of a Novel Multidrug and Toxin Extrusion (MATE) Transport Protein

  2005cited by this paper
• Bacterial efflux pump inhibition.

  2005cited by this paper
• Novel Chromosomally Encoded Multidrug Efflux Transporter MdeA in Staphylococcus aureus

  2004cited by this paper
• SEK‐1 MAPKK mediates Ca2+ signaling to determine neuronal asymmetric development in Caenorhabditis elegans

  2002cited by this paper
• The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus.

  2002cited by this paper
• Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureus.

  2002cited by this paper
• Transfer of Cationic Antibacterial Agents Berberine, Palmatine, and Benzalkonium Through Bimolecular Planar Phospholipid Film and Staphylococcus aureus Membrane

  2001cited by this paper
• Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor.

  2000cited by this paper
• Multiple Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus

  1999cited by this paper
• Bacteria lacking a multidrug pump: a sensitive tool for drug discovery.

  1998cited by this paper
• Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus

  1997cited by this paper
• Antibacterial activity and structure-activity relationships of berberine analogs

  1996cited by this paper
• Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter

  1993cited by this paper
• Validation of the general purpose QUANTA ®3.2/CHARMm® force field

  1992cited by this paper
• Characterization of a germ-line proliferation mutation in C. elegans.

  1992cited by this paper
• Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis

  1991cited by this paper
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

  1983cited by this paper
• Berberine sulfate: antimicrobial activity, bioassay, and mode of action.

  1969influential reference

• Plant natural products for antibacterial drug development against ESKAPE pathogens

  2025cites this paper
• Current development and structure-activity relationship study of berberine derivatives.

  2024cites this paper
• Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.

  2022cites this paper
• Single Molecule Non-cleavable Multiply Active Antibacterials

  2021cites this paper
• An Update on Staphylococcus aureus NorA Efflux Pump Inhibitors.

  2020cites this paper
• Multidrug Core–Shell Bead: A System for Bacterial Infection Treatment in Fish

  2019cites this paper
• Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

  2019influential citation
• Computational modelling of efflux pumps and their inhibitors.

  2017cites this paper
• Attaching the NorA Efflux Pump Inhibitor INF55 to Methylene Blue Enhances Antimicrobial Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo.

  2017cites this paper
• Emerging drugs and drug targets against tuberculosis

  2017cites this paper
• Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns.

  2017cites this paper
• C2 Arylated Benzo[b]thiophene Derivatives as Staphylococcus aureus NorA Efflux Pump Inhibitors

  2016cites this paper
• Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.

  2016cites this paper
• Multidrug efflux pumps and their inhibitors characterized by computational modeling

  2016cites this paper
• Beyond Traditional Antimicrobials: A Caenorhabditis elegans Model for Discovery of Novel Anti-infectives

  2016cites this paper
• Hybrid antibiotics – clinical progress and novel designs

  2016cites this paper
• Isolation and characterization of a novel (S)-canadine synthase gene from Coptis chinensis

  2015cites this paper
• Synthesis , characterization and antimicrobial evaluation of novel urea , sulfonamide and acetamide 3 , 4-dihydropyrazino [ 1 , 2-a ] indol-1 ( 2 H )-one derivatives

  2015influential citation
• Uptake of and Resistance to the Antibiotic Berberine by Individual Dormant, Germinating and Outgrowing Bacillus Spores as Monitored by Laser Tweezers Raman Spectroscopy

  2015influential citation
• Synthesis, characterization and antimicrobial evaluation of novel urea, sulfonamide and acetamide 3,4-dihydropyrazino[1,2-a]indol-1(2H)-one derivatives

  2015cites this paper
• Avaliação do envolvimento das bombas de efluxo na fármaco-resistência ao praziquantel em Schistosoma Mansonii

  2014influential citation
• Novel therapeutic approaches targeting Clostridium difficile

  2014cites this paper
• On the Mechanism of Berberine-INF55 (5-Nitro-2-phenylindole) Hybrid Antibacterials.

  2014cites this paper
• Culturing grass carp and grey mullet using food waste incorporated with traditional Chinese medicine, Baker's yeast and enzymes

  2013cites this paper
• C. elegans for anti-infective discovery.

  2013cites this paper
• Medicinal use of Coscinium fenestratum (Gaertn.) Colebr.: an short review

  2013cites this paper
• Strategies to Potentiate Antimicrobial Photoinactivation by Overcoming Resistant Phenotypes †

  2012cites this paper
• Characterization of two methylenedioxy bridge-forming cytochrome P450-dependent enzymes of alkaloid formation in the Mexican prickly poppy Argemone mexicana.

  2011cites this paper
• Microbial efflux pump inhibition: tactics and strategies.

  2011cites this paper
• Goldenseal: A case study on LC-MS profiling to identify synergists

  2011cites this paper
• Synthesis and Structural Characterization of 1-[2-(5-Nitro-1H-indol-2-yl)phenyl]methylpyridinium Chloride

  2011cites this paper
• Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis).

  2011cites this paper
• Caenorhabditis elegans-based model systems for antifungal drug discovery.

  2011cites this paper
• A mass spectrometric investigation of novel quadruplex DNA-selective berberine derivatives.

  2010cites this paper
• Synthesis of Berberine—Efflux Pump Inhibitor Hybrid Antibacterials

  2010cites this paper
• Send Orders of Reprints at Reprints@benthamscience.net Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation

  year unknowncites this paper